ArisGlobal, the Pioneer in Pharmacovigilance and Risk Management
ArisGlobal is a pioneer in the safety and pharmacovigilance space, bringing the first commercially available drug safety system to the life sciences industry. The company has over 30 years in delivering innovative solutions to a highly regulated and complex space with many “firsts” in its ongoing market leadership.
ArisGlobal was first to market with E2B in the year 2000 when new regulations were introduced, and most recently the company was the first to offer E2B R3 requirements in its products; and first to market with an IDMP solution. ArisGlobal was the first PV technology provider to enter Japan; and today the company has more relationships with health authorities across the globe than any other vendor on the market to manage public health safety. The company has never stopped growing or innovating, bringing improvements in efficiencies, regulatory compliance; and the best technology to its customers.
ArisGlobal company mission is to continue delivering most comprehensive technology based solutions designed to help life sciences companies achieve their most strategic objectives:
- .Maintaining compliance with government regulations
- .Bringing drugs and other products to market more efficiently
- .Improving patient safety by building a successful safety profile for their products
Global Customer Base
Currently, more than 200 life sciences companies, CROs and government health authorities around the world rely on ArisGlobal. Our unmatched experience in solving the real-world research and development needs of companies and organizations, including top Pharmas, Biotechs and Device manufacturers, CROs and regulatory agencies, makes ArisGlobal an established market leader in major regions of the world.
32 of the top 50 Biopharmaceutical companies rely on ArisGlobal solutions, and in fact, the company still maintains relationships with its initial customers from 30 years ago.
Leading Solutions for Adverse Event Reporting, Regulatory Tracking and e-Clinical
ArisGlobal customers rely on our technology platform to bring therapies to market faster and with greater cost effectiveness. Our success is based on our unequivocal commitment to develop leading and innovative cloud based software that help organizations maintain regulatory compliance, manage and mitigate risk, and improve operational efficiency.
Committed to innovation, customer success and regulatory compliance ArisGlobal cloud-based software is becoming the preferred choice for life sciences companies because it enables them to achieve quickly implement cost-effective solutions for drug safety, pharmacovigilance, clinical trials management, EDC, and regulatory tracking.